About
CANNADORF is dedicated to revolutionizing cannabis extraction by prioritizing the production of cannabinoids, terpenes, and flavonoids in a medically safe manner. The company envisions a future where medical-based cannabis drugs are consistently safe and reliable. CANNADORF aims to contribute to this vision by supplying pharmaceutical companies with high-quality and sterile extracts or Active Pharmaceutical Ingredients (APIs) without resorting to synthetic molecules.
The company is actively engaged in the development of a groundbreaking platform technology. This innovative approach involves the cultivation of sterile plant tissue in bioreactors, ensuring the commercial production of premium plant extracts or specific APIs. By adhering to the highest quality standards, CANNADORF strives to meet the diverse needs of pharmaceuticals, nutraceuticals, and cosmeceuticals markets while eliminating the use of synthetic additives.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Cannadorf's primary focus in the cannabis industry?
- Cannadorf is dedicated to revolutionizing cannabis extraction by prioritizing the production of cannabinoids, terpenes, and flavonoids in a medically safe manner, aiming to supply pharmaceutical companies with high-quality and sterile extracts or Active Pharmaceutical Ingredients (APIs).
- When was Cannadorf founded?
- Cannadorf was founded in February 2019.
- Where is Cannadorf headquartered?
- Cannadorf is headquartered in Tel Aviv-Yafo, Israel.
- What is Cannadorf's current funding stage?
- According to startupim data, Cannadorf is currently in the Pre-Funding stage.
- How many employees does Cannadorf have?
- Cannadorf has 2 employees.
- What markets does Cannadorf aim to serve with its products?
- Cannadorf aims to meet the needs of the pharmaceuticals, nutraceuticals, and cosmeceuticals markets.
- What kind of technology is Cannadorf developing?
- Cannadorf is developing a platform technology for the cultivation of sterile plant tissue in bioreactors to ensure the commercial production of premium plant extracts or specific APIs.
- What is the business model of Cannadorf?
- Cannadorf operates with B2B2C and B2B business models.
- What was a notable news event for Cannadorf in June 2022?
- In June 2022, news reported on a new Israeli development by Cannadorf: a device that prepares homemade RSO oil in 20 minutes.